Improving medical students

Saxagliptin Approved (DPP4 inhibitor)

Posted by medliorator on August 3, 2009


[Saxagliptin] which will be sold under the brand name Onglyza, is in a relatively new class, called DPP-4 inhibitors, that can be taken along with older diabetes drugs.

Until now, Merck’s Januvia has been the only drug in the class on the market in this country.

Saxagliptin Approval: Finally, Competition for Merck’s Januvia [WSJ Health Blog

Sorry, the comment form is closed at this time.

%d bloggers like this: